Internal Medicine Alert – October 15, 2018
October 15, 2018
View Issues
-
Revised Anticoagulation Therapy Guidelines for Atrial Fibrillation Patients
More patients with atrial fibrillation may receive anticoagulation, according to new recommendations.
-
Are In-hospital Deaths Related to Community-acquired Pneumonia Preventable?
This secondary analysis of data from five tertiary care centers found that among patients hospitalized for community-acquired pneumonia, very few deaths potentially were related to a lapse in in-hospital quality of pneumonia care.
-
Home-based Detection of Undiagnosed Atrial Fibrillation
In patients with risk factors for atrial fibrillation, screening with a self-applied wearable ECG patch resulted in significantly increased rates of new atrial fibrillation diagnoses within four months, along with greater use of anticoagulants and healthcare resources.
-
Eravacycline Injection (Xerava)
The FDA has approved a new parenteral, broad-spectrum antibiotic in the tetracycline class for the treatment of complicated intra-abdominal infections.
-
Biventricular Hypertrophy in an Asymptomatic Patient?